How many GABA-A patents are there?
There isn’t a single, universally agreed number for “GABA-A patents” because patents depend on (1) how “GABA-A” is defined (GABA-A receptor vs. “GABAergic” drugs), and (2) which patent databases and search terms are used. With the information provided here, the total number can’t be determined reliably.
What counts as a “GABA-A patent” in practice?
People usually mean patents that claim one of these:
- Targets or pathways involving the GABA-A (GABA-A receptor/benzodiazepine site or related modulatory sites).
- Compounds described as GABA-A receptor agonists, positive allosteric modulators, or antagonists.
- Methods (screening, biomarkers, formulations) specifically tied to GABA-A modulation.
Even if two searches both say “GABA-A,” they can return very different totals if one search includes broader terms like “GABAergic,” “benzodiazepine receptor,” or “chloride channel.”
Can you estimate the number with a search strategy?
Yes, but you’d need at least:
- The patent database(s) (e.g., Google Patents, Lens.org, Espacenet, USPTO).
- The exact search query (keywords/assignee/classes).
- The date range (all years vs. last 20 years).
- Whether you want published applications, granted patents, or both.
If you tell me which database and what you mean by “GABA-A” (receptor only, or also GABAergic modulators), I can help you design a query that produces a defensible count.
Quick clarification questions
1) Do you mean GABA-A receptor specifically, or GABAergic drugs in general?
2) Do you want granted patents only, or published applications too?
3) Which country/jurisdiction (US, EP, worldwide), and which database?
What I need to answer exactly
Share the database and search terms you’re using (or paste your search results link). Then the number of matches can be computed from that specific query.
Sources
None provided.